PMINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Picard Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$15.45+2.70 (+21.18%)
Close on Oct 19, 2026
- Market cap
- $28.67M
- P/E (TTM)
- –
- Dividend yield
- –
Picard Medical, Inc. revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Product [Member] | $5.88M | $5.08M | $4.75M | $4.62M | $4.38M | – | $4.25M | 93.3% | +34.2% |
| Rentals [Member] | $420.00K | $401.00K | $194.00K | $159.00K | $87.00K | – | $137.00K | 6.7% | +382.8% |
By region
From the segment and revenue-disaggregation notes of Picard Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.